Since BDNF plays a key role in neural plasticity, development, and cell survival by facilitating synaptogenesis, neural sprouting, neurogenesis, and reactive gliosis, the astrocytic Kir4.1-BDNF system is expected to serve as a novel target for the treatment of CNS disorders. This evidence concerns the gene KCNJ10 and central nervous system disorder.